Development of a Neutralizing Antibody Specific for the Active Form of Matrix Metalloproteinase-13
Authors:
- 23 October 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 51 (44) , 8877-8884
Abstract
Matrix metalloproteinase-13 (MMP-13) is important in the pathology of osteoarthritis (OA). Although MMP-13 is considered a therapeutic target for OA, it is unclear how MMP-13 activity is regulated by the system that comprises various proteinases and their inhibitors. MMP-13 neutralizing antibodies could be a useful tool for investigating the involvement of MMP-13 in cartilage degeneration in OA-affected joints because antibodies possess high affinity and specificity compared with low-molecular weight chemical compounds. On the basis of three-dimensional structure and amino acid sequence information on MMP-13, we selected an appropriate antigen peptide and generated a neutralizing antibody by immunizing mice with the antigen. The most significant property of monoclonal antibody 14D10 was the specific binding to the active form of MMP-13, but not to the latent form, or other MMPs. With this property, active MMP-13 was measured selectively by an enzyme-linked immunosorbet assay. Furthermore, 14D10 suppressed the cleavage of type II collagen in human articular chondrocyte cultures, and 14D10 is thought to inhibit MMP-13 activity effectively. Thus, the highly selective MMP-13 neutralizing antibody (14D10) might be a useful tool for investigating the mechanism of type II collagen degradation in arthritic pathology.Keywords
This publication has 24 references indexed in Scilit:
- Insurer and out‐of‐pocket costs of osteoarthritis in the US: Evidence from national survey dataArthritis & Rheumatism, 2009
- Changes in surgical loads and economic burden of hip and knee replacements in the US: 1997–2004Arthritis Care & Research, 2008
- Joint Diseases and Matrix Metalloproteinases: A Role for MMP-13Current Pharmaceutical Biotechnology, 2008
- Matrix Metalloproteinases: Role In ArthritisFrontiers in Bioscience-Landmark, 2006
- Regulation of matrix metalloproteinases: An overviewMolecular and Cellular Biochemistry, 2003
- Osteoarthritis of the peripheral jointsBest Practice & Research Clinical Rheumatology, 2002
- Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in miceJournal of Clinical Investigation, 2001
- Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.Journal of Clinical Investigation, 1997
- Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.Journal of Clinical Investigation, 1996
- Biochemical Characterization of Human Collagenase-3Journal of Biological Chemistry, 1996